Table 2.
Serial changes in lipid parameters, hsCRP, and CD34+/133+ cell numbers
| Pitavastatin (n = 53) | Control (n = 22) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 3 M | 6 M | p value | Baseline | 3 M | 6 M | p value | |
| Lipid parameters | ||||||||
| T-Chol (mg/dL) | 207 ± 40 | 158 ± 29 | 159 ± 29 | <0.0001 | 193 ± 39 | 197 ± 39 | 196 ± 43 | 0.215 |
| TG (mg/dL) | 154 ± 82 | 124 ± 81 | 126 ± 88 | 0.005 | 115 ± 51 | 101 ± 45 | 103 ± 42 | 0.057 |
| HDL-C (mg/dL) | 51 ± 14 | 53 ± 13 | 53 ± 12 | 0.220 | 52 ± 12 | 53 ± 14 | 55 ± 15 | 0.065 |
| LDL-C (mg/dL) | 123 ± 32 | 79 ± 22 | 82 ± 21 | <0.0001 | 115 ± 38 | 131 ± 37 | 116 ± 42 | 0.274 |
| hsCRP (mg/dL) | 0.31 ± 0.60 | 0.38 ± 0.70 | 0.17 ± 0.15 | 0.056 | 0.22 ± 0.23 | 0.23 ± 0.23 | 0.23 ± 0.26 | 0.577 |
| Log10CD34+/133+ cells | 1.67 ± 0.29 | 1.73 ± 0.31 | 1.74 ± 0.29 | 0.923 | 1.73 ± 0.29 | 1.65 ± 0.24 | 1.68 ± 0.31 | 0.259 |
Values are expressed as mean ± SD. Statistical significance was defined as * p < 0.05
HDL-C high-density lipoprotein cholesterol, hsCRP high-sensitivity C-reactive protein, LDL-C low-density lipoprotein cholesterol, M months, T-Chol total cholesterol, TG triglycerides